» Articles » PMID: 35534573

Macrophage Functional Diversity in NAFLD - More Than Inflammation

Overview
Specialty Endocrinology
Date 2022 May 9
PMID 35534573
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophages have diverse phenotypes and functions due to differences in their origin, location and pathophysiological context. Although their main role in the liver has been described as immunoregulatory and detoxifying, changes in macrophage phenotypes, diversity, dynamics and function have been reported during obesity-related complications such as non-alcoholic fatty liver disease (NAFLD). NAFLD encompasses multiple disease states from hepatic steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis and hepatocarcinoma. Obesity and insulin resistance are prominent risk factors for NASH, a disease with a high worldwide prevalence and no approved treatment. In this Review, we discuss the turnover and function of liver-resident macrophages (Kupffer cells) and monocyte-derived hepatic macrophages. We examine these populations in both steady state and during NAFLD, with an emphasis on NASH. The explosion in high-throughput gene expression analysis using single-cell RNA sequencing (scRNA-seq) within the last 5 years has revolutionized the study of macrophage heterogeneity, substantially increasing our understanding of the composition and diversity of tissue macrophages, including in the liver. Here, we highlight scRNA-seq findings from the last 5 years on the diversity of liver macrophages in homeostasis and metabolic disease, and reveal hepatic macrophage function beyond their classically described inflammatory role in the progression of NAFLD and NASH pathogenesis.

Citing Articles

Diverse Functions of Macrophages in Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease: Bridging Inflammation and Metabolism.

Jang J, Sung J, Huh J Immune Netw. 2025; 25(1):e12.

PMID: 40078789 PMC: 11896663. DOI: 10.4110/in.2025.25.e12.


Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease.

Zhang L, Liu S, Zhao Q, Liu X, Liu T, Zhang Q World J Hepatol. 2025; 17(2):102328.

PMID: 40027566 PMC: 11866134. DOI: 10.4254/wjh.v17.i2.102328.


Exploring the hepatic-ophthalmic axis through immune modulation and cellular dynamics in diabetic retinopathy and non-alcoholic fatty liver disease.

Zhang S, Wu J, Wang L, Zhang C, Zhang Y, Feng Y Hum Genomics. 2025; 19(1):19.

PMID: 40011971 PMC: 11866823. DOI: 10.1186/s40246-025-00730-z.


GAMG alleviates liver fibrosis through inducing ferroptosis in inflammatory macrophages via the IRF1/SLC7A11 signaling pathway.

Pang Q, Zhou S, Wang Y, Pan H, Wang Z, Wang Z Redox Biol. 2025; 80:103509.

PMID: 39904190 PMC: 11847116. DOI: 10.1016/j.redox.2025.103509.


Decoding liver fibrogenesis with single-cell technologies.

Zhou T, Kiran M, Lui K, Ding Q Life Med. 2025; 1(3):333-344.

PMID: 39872749 PMC: 11749458. DOI: 10.1093/lifemedi/lnac040.


References
1.
Gordon S, Pluddemann A . Tissue macrophages: heterogeneity and functions. BMC Biol. 2017; 15(1):53. PMC: 5492929. DOI: 10.1186/s12915-017-0392-4. View

2.
Liddiard K, Taylor P . Understanding local macrophage phenotypes in disease: shape-shifting macrophages. Nat Med. 2015; 21(2):119-20. DOI: 10.1038/nm.3798. View

3.
Pollard J . Trophic macrophages in development and disease. Nat Rev Immunol. 2009; 9(4):259-70. PMC: 3648866. DOI: 10.1038/nri2528. View

4.
Krenkel O, Tacke F . Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017; 17(5):306-321. DOI: 10.1038/nri.2017.11. View

5.
Wen Y, Lambrecht J, Ju C, Tacke F . Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cell Mol Immunol. 2020; 18(1):45-56. PMC: 7852525. DOI: 10.1038/s41423-020-00558-8. View